作者: Meimei Liu , Yan Li , Shang-Tian Yang
DOI: 10.1002/TERM.1911
关键词:
摘要: Human amniotic fluid-derived stem cells (hAFSCs) are a novel cell source for generating osteogenic to treat bone diseases. Effective induction of differentiation from hAFSCs is critical fulfil their therapeutic potential. In this study, naringin, the main active compound Rhizoma drynariae (a Chinese herbal medicine), was used stimulate proliferation and hAFSCs. The results showed that naringin enhanced alkaline phosphatase activity (ALP) in dose-dependent manner range 1-100 µg/ml, while an inhibition effect observed at 200 µg/ml. Consistently, calcium content also increased with concentration up 100 by further confirmed upregulation marker genes, including osteopontin (OPN) Collagen I RT-PCR analysis. osteoprotegerin (OPG) expression minimal receptor activator nuclear factor-κB ligand (RANKL) suggested inhibited osteoclastogenesis addition, gene expressions morphogenetic protein 4 (BMP4), runt-related transcription factor 2 (RUNX2), β-catenin Cyclin D1 significantly, indicating promotes osteogenesis via BMP Wnt-β-catenin signalling pathways. These can be upregulate hAFSCs, which could provide attractive promising treatment disorders. Copyright © 2014 John Wiley & Sons, Ltd.